Press Releases

CHICAGO, June 03, 2024 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that its Board of Directors has declared a distribution of $0.25 per share for the second quarter of 2024, payable on June 28, 2024 to stockholders of record as of June 17, 2024. In October 2012, the Company adopted a dividend reinvestment plan that provides for reinvestment of distributions on behalf of its stockholders, unless a stockholder elects... (continue reading...)

SKOKIE, Ill., June 3, 2024 /PRNewswire/ -- Maya Romanoff, the largest multi-disciplinary manufacturer of handcrafted wallcoverings in the United States, is proud to announce the launch of its highly anticipated Spring 2024 collections, featuring three captivating additions: Bouquet™, Timantti™, and an expanded collection of Natural Elements™. These collections represent the pinnacle of creativity, craftsmanship, and sophistication, showcasing Maya Romanoff's... (continue reading...)

Highlights of the first quarter include:

• Revenue of $287.6 million, an increase of 18% compared to $244.4 million in Q1 FY24.
• Net income of $28.8 million, compared to $4.1 million in Q1 FY24, with non-GAAP net income of $70.3 million, an increase of 64% compared to $42.8 million in Q1 FY24.
• Net income per diluted share of $0.33, compared to $0.05 in Q1 FY24, with non-GAAP net income per diluted share of $0.80, compared to $0.50 in Q1 FY24.
• Adjusted EBITDA of... (continue reading...)

Board of Directors Authorizes $15.0 Million Share Repurchase Program

NEW YORK--(BUSINESS WIRE)-- BARK, Inc. (NYSE: BARK) (“BARK” or the “Company”), a leading global omnichannel dog brand with a mission to make all dogs happy, today announced its financial results for the fiscal fourth quarter and full year ended March 31, 2024.

Fiscal Fourth Quarter 2024 Highlights

• Delivered revenue of $121.5 million, the midpoint of the guidance range.
• Gross... (continue reading...)

MINNEAPOLIS, June 03, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Jefferies Global Healthcare Conference to be held in New York on June 4-6, 2024.

Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, is scheduled for a fireside chat at 10:00 a.m. ET on Thursday, June 6, 2024. A live webcast of the event... (continue reading...)